2025-09-25 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc. (UNH) based on the data you provided.  It's structured to present the key metrics and insights in a clear and concise manner, suitable for a quick review in English.

## UNH Stock Analysis (September 25, 2025)

**Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company providing a wide range of health benefits and services.

### 1. Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** 3.62%
*   **VOO Cumulative Return:** 69.58%
*   **Igridance:**
    *   **Current:** -77.0
    *   **Max:** 55.3
    *   **Min:** -101.4
    *   **Relative Igridance:** 15.6

**Analysis:** UNH has significantly underperformed the S&P 500.  The Igridance is currently at -77.0, indicating a substantial performance gap.  The Relative Igridance of 15.6 suggests the current underperformance is near the lower end of its historical range relative to the S&P 500, meaning the underperformance is at its worst point over the period analyzed.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2015-2017  | 41.0%  | 89.4%  | 16.0%  | 0.1   | 199.7  |
| 2016-2018  | 33.0%  | 80.8%  | 15.0%  | 0.1   | 225.7  |
| 2017-2019  | 19.0%  | 80.8%  | -7.0%  | 0.2   | 266.3  |
| 2018-2020  | -39.0% | 99.6%  | -50.0% | 0.5   | 317.7  |
| 2019-2021  | 13.0%  | 99.6%  | -16.0% | 1.1   | 454.9  |
| 2020-2022  | 5.0%   | 99.6%  | 10.0%  | 1.5   | 480.3  |
| 2021-2023  | 20.0%  | 99.6%  | 9.0%   | 0.6   | 477.0  |
| 2022-2024  | -25.0% | 99.6%  | -49.0% | 0.4   | 458.3  |
| 2023-2025  | -25.0% | 99.2%  | -64.0% | 0.4   | 316.8  |

**Analysis:**  The table shows a fluctuating Alpha and Beta over different periods. The Alpha has been negative in recent years, indicating underperformance relative to its risk-adjusted benchmark.  The Beta values have also varied, showing the stock's changing volatility relative to the market. High MDD percentages over the years should also be noted.

### 2. Recent Price Action

*   **Current Price:** 349.65
*   **Last Market Close:**
    *   **Price:** 349.7581
    *   **Previous Close:** 347.69
    *   **Change:** 0.59
*   **5-Day Moving Average:** 340.814
*   **20-Day Moving Average:** 328.409
*   **60-Day Moving Average:** 298.9097

**Analysis:** The stock is trading above its 5, 20, and 60-day moving averages, suggesting a short-term uptrend.  The last market change indicates a slight increase, potentially reinforcing the upward momentum.

### 3. Market Risk Indicators

*   **Market Risk Indicator (MRI):** 0.434 (Medium Risk)
*   **RSI:** 74.49 (Overbought)
*   **PPO:** -0.18
*   **Hybrid Signal:** Cash_0%_Buy 50% of cash (1 shares - Caution - MRI:0.42)
*   **Recent Relative Igridance Change (20-day):** -4.9 (Negative - short-term decline)
*   **Expected Return:** 35.8% (Long-term, vs. S&P 500)

**Analysis:**

*   The MRI suggests medium market risk.
*   The RSI is in overbought territory, potentially indicating a pullback.
*   The PPO is negative, although close to zero.
*   The hybrid signal recommends buying 50% of available cash, but with caution.
*   The negative change in relative Igridance indicates a recent decline in performance compared to the S&P 500.
*   The expected return is high (35.8%), suggesting significant potential outperformance over the long term, but this should be considered in light of the current underperformance.
*   Price slightly increased, possibly signaling a short-term issue and rebound.

### 4. Recent News & Significant Events

*   **Positive Analyst Updates:** Truist and Leerink Partners raised price targets.
*   **Billionaire Interest:** Warren Buffett and Bill Ackman recently bought UNH shares.
*   **Positive Sentiment:** Articles suggesting the worst may be over for UNH stock.
*   **Fund's Confidence:** Mairs & Power Balanced Fund is holding UNH despite challenges.

**Analysis:** The news flow is generally positive. Analyst upgrades and billionaire investments suggest confidence in the company's future prospects.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (~1.96 on a 1-5 scale)
*   **Opinions:** 24
*   **Target Price:**
    *   **Average:** $342.58
    *   **High:** $626.00
    *   **Low:** $198.00

**Analysis:** Analyst sentiment is generally positive, with a "Buy" consensus. The average target price is slightly below the current price, but the wide range suggests considerable uncertainty.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-08-11 | 3.76  | 111.62 B$  |
| 2025-05-07 | 6.9   | 109.58 B$  |
| 2024-11-04 | 6.56  | 100.82 B$  |
| 2024-08-09 | 4.58  | 98.86 B$   |
| 2025-08-11 | 4.58  | 98.86 B$   |

**Analysis:**  Revenue has been generally increasing, but EPS has been fluctuating. The most recent EPS (3.76) is lower than the previous quarter (6.9). Note: 2025-08-11 row duplicated, potential data entry error.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue     | Profit Margin |
|------------|-------------|---------------|
| 2025-06-30 | $111.62B    | 17.93%        |
| 2025-03-31 | $109.58B    | 21.70%        |
| 2024-12-31 | $100.81B    | 21.14%        |
| 2024-09-30 | $100.82B    | 22.84%        |
| 2024-06-30 | $98.86B     | 22.31%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE   |
|------------|-------------|-------|
| 2025-06-30 | $94.72B    | 3.60% |
| 2025-03-31 | $95.04B    | 6.62% |
| 2024-12-31 | $92.66B    | 5.98% |
| 2024-09-30 | $94.53B    | 6.41% |
| 2024-06-30 | $89.36B    | 4.72% |

**Analysis:**

*   Revenue has generally increased over the past year.
*   Profit margin has decreased in the most recent quarter.
*   Equity has fluctuated.
*   ROE has decreased significantly in the most recent quarter.

### 7. Overall Analysis

UNH is currently underperforming the S&P 500 significantly. While recent news and analyst sentiment are generally positive, and billionaires seem to be buying in, the technical indicators suggest caution (overbought RSI, negative relative Igridance change). The recent earnings and financial data show increasing revenue but declining profit margins and ROE.

**In summary:** UNH presents a mixed picture. There are potential positive catalysts, but the current underperformance and some weakening financial metrics warrant careful consideration. The high expected return should be weighed against the current challenges.
